Artiva Biotherapeutics is advancing NK cell therapy and CAR-NK therapy for cancer, including blood cancers and solid tumors.

Biotechnology

Education

Artiva Biotherapeutics

Artiva Biotherapeutics' headquarters in San Diego, CA, United States

Fred Aslan

Andrew Cronauer

Thad Huston

John O'Neil

Thorsten Graef

Nicholas Veomett

Jennifer Bush

Jae Park

Evren Alici

Linda Kozick

Elizabeth Hougen

Laura Stoppel

Laura Bessen

James Park

Yvonne Yamanaka

Brian Daniels

Yong-Jun Huh

Richard Maziarz

Kenneth Kalunian

Jill Buyon

Brad Rovin

Maureen McMahon

The Directors and Associate Directors at Artiva Biotherapeutics oversee strategic functions essential for advancing NK cell and CAR-NK therapies. They lead critical departments such as Facilities, Talent Acquisition, IT, Quality Assurance, Laboratory Operations, and Project & Alliance Management, ensuring synchronized efforts for pioneering cancer treatments.

Directors and Associate Directors

The Leadership Team at Artiva Biotherapeutics is responsible for setting the strategic direction and overseeing the execution of the company's mission to advance NK cell and CAR-NK therapies for cancer. This diverse team collaborates across technical operations, regulatory affairs, research, clinical development, and legal matters to ensure the successful development and commercialization of innovative therapies, while fostering a culture of excellence and compliance.

Leadership Team

The Advisory Team at Artiva Biotherapeutics provides strategic guidance and expert insights to advance the development and clinical application of NK cell and CAR-NK therapies for cancer treatment. They leverage their extensive experience to support decision-making processes, optimize therapeutic approaches, and foster partnerships within the medical and scientific communities.

Advisory Team

This department ensures the integrity and compliance of products and processes through meticulous quality control and assurance practices.

Quality Assurance

The Research and Pharmaceutical Sciences team at Artiva Biotherapeutics focuses on advancing natural killer (NK) cell therapy and CAR-NK therapy for treating blood cancers and solid tumors. They conduct cutting-edge research and translational science in pharmacology, aiming to innovate and enhance therapeutic strategies for effective cancer treatment.

Research and Pharmaceutical Sciences

The Clinical Operations Team at Artiva Biotherapeutics coordinates and manages clinical trials for NK cell and CAR-NK therapies aimed at treating blood cancers and solid tumors. They oversee trial logistics, ensure compliance with GMP quality standards, and facilitate seamless execution from initial planning through to regulatory submission.

��

Artiva Biotherapeutics

Org chart

Board & advisors

Teams

Directors and Associate Directors

Leadership Team

Advisory Team

Quality Assurance

Research and Pharmaceutical Sciences

Clinical Operations Team

Offices

��������

Artiva Biotherapeutics

Org chart

Board & advisors

Teams

Directors and Associate Directors

Leadership Team

Advisory Team

Quality Assurance

Research and Pharmaceutical Sciences

Clinical Operations Team

Offices

Related companies

��